- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Pakistani Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨119.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨374.67
7D
-0.3%
1Y
171.3%
Highnoon Laboratories
Market Cap: PK₨48.3b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨911.09
7D
-0.4%
1Y
37.1%
Hoechst Pakistan
Market Cap: PK₨30.4b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,150.14
7D
-7.3%
1Y
125.0%
Abbott Laboratories (Pakistan)
Market Cap: PK₨94.8b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨968.03
7D
1.8%
1Y
42.5%